We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.
Copyright West LLC. Minimum 15 minutes delayed.
10:30 AM EDT
|16th Annual Morgan Stanley Global Healthcare Conference|
1:45 PM EDT
|20th Annual Rodman & Renshaw Global Investment Conference|
4:30 PM EDT
|Second Quarter 2018 Financial Results|